Study in Subjects With Light Chain (AL) Amyloidosis
NCT03154047
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
80
Enrollment
INDUSTRY
Sponsor class
Stopped
NEOD001 program terminated due to lack of clinical benefit
Conditions
AL Amyloidosis
Interventions
DRUG:
NEOD001
Sponsor
Prothena Biosciences Ltd.